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Abstract. Case Based Reasoning has been applied in different fields such as
medicine, industry, tutoring systems and others, but in the CBR there are many ar-
eas to explore. Nowadays, some research works in Bioinformatics are attempting
to use CBR like a tool for classifying DNA genes. Specially the microarrays have
been applied increasingly to improve medical decision-making, and to the diagno-
sis of different diseases like cancer. This research work analyzes the Microarrays
structure, and the initial concepts to understand how DNA structure is studied in
the Bioinformatics’ field. In last years the CBR has been related to Bioinformatics
and Microarrays. In this report, our interest is to find out how the Microarrays tech-
nique could help in the CBR field, and specially in the Case-Based Maintenance
policies.
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1. Introduction
DNA microarray technology is attracting tremendous interest both among the scientific
community and in industry. With its ability to measure simultaneously the activities and
interactions of thousands of genes, this modern technology promises new insights into
the mechanisms of living systems. Typical scientific questions addressed by microar-
ray experiments include the identification of co-expressed genes, either as genes ex-
pressed throughout a sub-population or as genes always expressed together (sample or
gene groups), identification of genes whose expression patterns make it possible to dif-
ferentiate between biological entities that are otherwise indistinguishable, and the study
of gene activity patterns under various stress conditions (e.g., chemical treatment). Al-
though microarrays have been applied in many biological studies, the handling and anal-
ysis of the large volumes of data generated is not trivial. Different types of scientific
questions require different data analytical techniques. Broadly speaking, there are two
classes of elementary data analysis tasks, predictive modeling and pattern-detection. Pre-
dictive modeling tasks are concerned with learning a classification or estimation func-
tion, whereas pattern-detection methods screen the available data for interesting and pre-
viously unknown regularities or relationships. A wide range of sophisticated methods
and tools have been developed to address these tasks.
2 CBR and Microarrays
One of the main reasons why researchers are pursuing DNA microarray studies with
such intensity, in the full knowledge of their limitations, is the fact that protein expression
and modification studies are still very expensive, and often involve highly specialized
and delicate techniques.
CBR has been applied successfully in different fields, but in the field of Bioinfor-
matics has been applied relatively less frequently. Actually there are a few papers in this
field. Molecular Biology domain is a natural application for CBR systems, since CBR
can perform remarkably well on complex and poorly formalized domains. CBR is spe-
cially used in different areas which incorporate the fields of biology, computer science
among others. One of the applications in this research line is the sequence analysis where
involves the study of organism’s DNA, to understand its molecular structure which has
led to the discovery of mutation in DNA and chromosomal abnormalities indicative of
diseases such cancer. In this field of cancer diseases there are research work such as
[2,3,4] where CBR is applied to help to the studies of DNA. Specially in research [2], has
as main task the gene finding by applying CBR by employing a case library of nucleotide
segments that have previously been categorized. While in the research work [3] presents
an approach to performing the case-based paradigm in the presence of noisy DNA se-
quences (case boundaries), applied in the domain of molecular biology. And GENE-
CBR application to study cancer treatment is presented in [4], where presents a reduction
algorithm based on notion of fuzzy codification for gene expression level employed to
implement the retrieval step.
Others research works are focused in the use of a CBR classifier attribute as a clas-
sifier in microarray data field. For instance, in the research works [7,9] propose a main-
tenance technique that integrates an ensemble of CBR classifiers with spectral clustering
to improve classification accuracy of CBR on (ultra) high-dimensional biological data
sets. The main challenge of [7,9] is to interpret the molecular biology data, and find sim-
ilar samples to eventually use them in case-based medicine, and to identify genes with
meaningful relationships.
The aim of this research is to describe in short terms, how the Bioinformatics field
is becoming interesting to the CBR community, and to show some research works such
as there cited before. That involves the CBR, Bioinformatics and the Microarrays into
novelties applications. To understand and using microarrays analysis techniques requires
a basic understanding of the fundamental mechanism of gene expressions, for that the
research begins with a brief description of it. One time, with the knowledge of DNA the
microarray data analysis is explained in the Bioinformatics section. Microarrays as CBR
have many topics of data mining, for it an introduction of each topic is introduced in
the same section of Bioinformatics. In features sections the task of find genes with CBR
is described taking into account some research works. The CBR community has been
working in systems that could help making advices in the treatment of the cancer disease,
for that some research works are described, and finally the use of microarray with CBR
are described based on the research works of Niloofar Arshadi.
2. Fundamentals Topics of Bioinformatics
Understanding and using microarray analysis techniques requires a basic understanding
of the fundamental mechanisms of gene expression itself. Describing gene expression
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starts necessarily with deoxyribonucleic acid (DNA), the very stuff genes are made from,
and ribonucleic acid (RNA). Both DNA and RNA are polymers, that is, molecules that
are constructed by sequentially binding members of a small set of subunits called nu-
cleotides into a linear strand or sequence. Each nucleotide consists of a base, attached to
a sugar, which is attached to a phosphate group. The linear strand consists of alternate
sugars and phosphates, with the bases protruding from the sugars. In DNA, the sugar is
deoxyribose and the bases are named guanine, adenine, thymine, and cytosine; in RNA
the sugar is ribose and the bases are guanine, adenine, uracil, and cytosine [8]. The
sugar phosphate backbone can, for the purposes of informatics, be considered as straight
(though actually it has all sorts of twists, kinks and loops (higher order structures) that
are of interest to those who care about such things). The bases that protrude from the
backbone are far more informative. They can form pairs, via hydrogen bonds, with bases
in other nucleic acid strands: adenine binds to thymine (or uracil) and guanine to cyto-
sine, by the formation of two and three hydrogen bonds respectively. Such base pairing
allows DNA to be organized as a double-stranded polymer whose characteristic three-
dimensional helix structure has become famous. The two DNA strands are complemen-
tary to each other, meaning that every guanine in one strand corresponds to a cytosine
in the other (complementary) strand. The same mechanisms apply to the complementary
DNA nucleotides adenine and thymine.
Within the DNA, genes are unique sequences of variable length. The genes within
a cell comprise the cell’s genome: it contains the information necessary for synthesiz-
ing (constructing) proteins, which do all that a cell needs. The genome also contains
the information that controls which proteins are synthesized in a given cell under par-
ticular circumstances. Implicit in the structure of a cell’s genome are mechanisms for
self replication and for transforming gene information to proteins. The gene to protein
transformation constitutes the "central dogma of molecular biology"; it is described by a
two-step process (Expression): Step 1: Transcription: Gene(DNA) makes RNA, Step 2:
Translation: RNA makes protein.
That is, the information represented by the DNA sequence of genes is transferred
into an intermediate molecular representation, an RNA sequence, using part of a DNA
strand as a template for assembling the RNA. The information represented by the RNA
is then used as a template for constructing proteins, according to a code in which each
amino acid is represented by three bases in the RNA. The RNA occurring as intermediate
structure is referred to as messenger RNA (mRNA). The term transcription is commonly
used to describe Step 1 and the term translation for Step 2. Collectively, the overall
process consisting of transcription and translation is known as gene expression. Notice,
in most organisms only a small subset of genomic DNA is capable of being transcribed
to mRNA or expressed as proteins. Some regions of the genome are devoted to control
mechanisms, and a substantial amount of the genomes of higher-level organisms appears
to serve no informational function at all. These DNA sections are also known as junk
DNA.
Hybridization
This section will illustrate the biochemical principles involved in measuring transcripts
with microarrays. A number of techniques have been developed for measuring gene ex-
pression levels, including northern blots, differential display, and serial analysis of gene
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expression. DNA and oligonucleotide microarrays are the latest in this line of methods.
They facilitate the study of expression levels in parallel. All these techniques exploit a
potent feature of the DNA duplex (the sequence complementarity of the two strands).
This feature makes hybridization possible. Hybridization is a chemical reaction in which
single-stranded DNA or RNA molecules combine to form double stranded complexes
(see schematic illustration in Figure 1). The famous DNA double helix is an example of
such a molecular structure. The hybridization process is governed by the base-pairing
Figure 1. Hybridization of two single-stranded nucleic acid sequence to double-stranded, helical complex.
rules: specific bases in different strands form hydrogen bonds with each other. For DNA
the matching pairs are adenine-thymine and cytosine-guanine. Hybridization is a non-
linear reaction. Yield the number or concentration of nucleic acid elements binding with
each other in the resulting double-stranded molecule depends critically on the concen-
tration of the original single-stranded polymers and on how well their sequences align or
match. It is this yield that is measured in a microarray experiment. In order to selectively
detect and measure the amount of mRNA that is contained in an investigated sample,
we must label the mRNA with reporter molecules. The reporters currently used in mi-
croarray experiments include fluorescent dyes (fluors), for example, cyanine 3 (Cy3) and
cyanine 5 (Cy5). Assume having two samples of transcribed mRNA from two different
sources, sample 1 and sample 2. Both samples may consist of multiple copies of many
genes. They also a probe, which is a specific nucleic acid sequence, perhaps a gene, or
a characteristic subsequence of a gene, or a short, artificially composed nucleotide se-
quence. Like the two samples, the probe will contain many copies of the sequence in
question. This is important because sufficient amounts are needed to get the hybridiza-
tion reaction going, and to be able to detect and measure the various concentrations. If
want to find out is the relative abundance of the mRNA complementary to the probe se-
quence within sample 1 and sample 2. Sample 1, for example, may contain three times
as many copies of sequences complementary to the probe as sample 2, or they may not
be contained in either sample at all. To find out the exact answer, proceed as follows (see
also Figure 2):
1. Prepare a mixture consisting of identical probe sequences. In this scheme of
things the probe is a kind of "sitting duck", awaiting hybridization.
2. Label sample 1 with green-dyed reporter.
3. Label sample 2 with red-dyed reporter.
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Figure 2. Hybridization of two single-stranded nucleic acid sequence to double-stranded, helical complex.
4. Simultaneously give both sample mixtures the chance to hybridize with the probe
mixture. Here, sample 1 and sample 2 are said to compete with each other in an
attempt to hybridize with the probe.
5. Gently stir for five minutes.
6. Filter the mixture to retain only those probe sequences that have hybridized, that
is, formed a double-stranded polymer.
7. Measure the amount or intensity of green and red in the filtered mixture, and
compare the amounts to determine the relative abundance of the probe sequence.
8. Jot down the result, add a little salt, and enjoy.
The Matrix and Data
Microarray data analysis involves methodologies and techniques from life science fields
and biotechnology on one hand, and from computer science and statistics on the other.
With these broad disciplines comes a lot of heavy baggage in the form of terminology.
The term gene expression profile is commonly used to describe the expression values
for a single gene across many samples or experimental conditions, and for many genes
under a single condition or sample. They suggest the following terms to distinguish these
types of gene expression profiles (see Figure 3):
Figure 3. Typical gene expression data matrix formats. The solid-line boxes contain the actual numerical
values representing the measured expression levels
One gene over multiple samples. A gene profile is a gene expression profile that
describes the expression values for a single gene across many samples or conditions.
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Many genes over one sample. An array profile is a gene expression profile that describes
the expression values for many genes under a single (condition or) sample.
The diagram in Figure 3 depicts two commonly employed data formats for the in-
tegrated gene-expression data matrix. Left part in Figure 3. Concentrating on the gene
expression part only, this format can be described by an N x M expression matrix E, as
defined in Equation (1)
E = (Xij) =

x11 x12 . . . x1M
x21 x22 . . . x2M
...
...
. . .
xN1 xN2 . . . xNM
 (1)
where Xij denotes the expression level of sample j for gene i, such that j = 1, . . . M, and
i = 1, . . . N (Dudoit et al., 2000).
The expression matrix E is a convenient format to represent the expression pro-
files of N genes over M samples. Whether column vectors or row vectors in this ma-
trix are interpreted as variables (or observations) is not pre-determined by the matrix
format. However, the matrix does nail down the interpretation in terms of gene and ar-
ray profile. With Equation (1) define the ith gene profile of expression matrix E by
the row vector Gi, and the jth array profile of E by the column vector Aj , as follows:
Gi = (Xi1, Xi2, . . . , XiM ) and Aj = (Xj1, Xj2, . . . , XjN ).
The Microarrays
Based in the definition of a microarray of [16], "a microarray is an ordered array of
microscopic elements on a planar substrate that allows the specific binding of genes or
gene products. Microarray is a new scientific word derived from the Greek word mikro
(small) and the French word arayer (arranged). Microarrays (also know as biochips,
DNA chips, and gene chips) contain collections of small elements or spots arranged in
rows and columns. To qualify as a microarray, the analytical device must be (1) ordered,
(2) microscopic, (3) planar, and (4) specific. Devices that fullfill only a sub set of these
criteria do not afford the advantages of microarrays, do not qualify as microarrays, and
should not be considered as such".
DNA microarrays analyse (1) the mRNAs in a cell, to reveal the expression patterns
of proteins; or (2) genomic DNAs, to reveal absent or mutated genes. 1. For an integrated
characterization of cellular activity, if we want to determine what proteins are present,
where and in what amounts. To find the expression pattern of a cell’s genes, measure the
relative amounts of many different mRNAs. Hybridization is an accurate and sensitive
way to detect whether any particular nucleic acid sequence is present. The key to high-
throughput analysis is to run many hybridization experiments in parallel.
DNA microarrays, or DNA chips, are devices for checking a sample simultaneously
for the presence of many sequences.
Microarrays provide an efficient, high-throughput way of carrying out these tests in
parallel. They also permit measuring the expression levels of thousands or even tens of
thousands of genes in a single sample
To achieve parallel hybridization analysis, a large number of DNA oligomers are af-
fixed to known locations on a rigid support, in a regular two-dimensional array. The mix-
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ture to be analysed is prepared with fluorescent tags, to permit detection of the hybrids.
After exposing the array to the mixture, each element of the array to which some com-
ponent of the mixture has become attached bears the tag. Because the sequence of the
oligomeric probe in each spot in the array is known, measurement of the positions of the
probes identifies their sequences. This analyses the components present in the sample.
Different types of chips designed for different investigations differ in the types of
DNA immobilized.
• In an expression chip, the immobilized oligos are cDNA samples, typically 20-
80 base pairs long, derived from mRNAs of known genes. The goal of such an
experiment is to determine the expression patterns of genes that correspond to the
cDNA samples. This is by far the most common application of microarrays. The
target sample might be a mixture of mRNAs from normal or diseased tissue.
• In mutation microarray analysis, one looks for patterns of single-nucleotide poly-
morphisms (SNPs).
• In genomic hybridization, one looks for gains or losses of genes, or changes in
copy number. The probe sequences, fixed on the chip, are large pieces of genomic
DNA, from known chromosomal locations, typically 500-5000 base pairs long.
The probe mixtures contain genomic DNA from normal or disease states. For
instance, some types of cancer arise from chromosome deletions, which can be
identified by microarrays.
Microarrays are capable of comparing concentrations of components of the sample. This
allows quantitative investigation of responses to changed conditions. However, the preci-
sion is low. Moreover, mRNA levels, detected by the array, do not always accurately re-
flect protein levels. Indeed, usually mRNAs are reverse transcribed into more stable cD-
NAs for microarray analysis; the yields in this step may also be non uniform. Microarray
data are therefore semiquantitative, in that a distinction between presence and absence
is possible, determination of relative levels of expression in a controlled experiment is
more difficult, and measurement of absolute expression levels are beyond the capacity
ofcurrent microarray techniques.
Analysis of microarray data
The raw data of a microarray experiment is an image, in which the colour and intensity
of the fluorescence reflect the extent of hybridization to alternative probes. The two sets
of probes are tagged with red and green fluorophores. If only one probe hybridizes, the
spot appears red; if only the other probe hybridizes. The spot appears green. If both
hybridize, the colour of the corresponding spot appears red + green = yellow. The initial
goal of data processing is a gene expression table. This is a matrix in which the rows
correspond to different genes, and the columns to different samples. Different spots in
a microarray pattern correspond to different genes. For each gene, results from different
sets of samples appear in the red or green channel, respectively (or neither, or both).
There is extensive redundancy in the oligos in a microarray each gene may be represented
by several spots, corresponding to different regions of the gene sequence; inclusion of
controls with a deliberate mismatch allows data verification.
The samples may vary according to experimental conditions and/or physiological
states. Or they may be extracted from different individuals, different tissues or differ-
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ent developmental stages. The process of data reduction to produce the gene expression
matrix involves many technical details of image processing, checking internal controls,
dealing with missing data. Selecting reliable measurements, and putting the results of
different arrays on consistent scales. The derived gene expression table indicates relative
expression levels. Extraction of reliable biological information from a gene expression
table is not Straight-forward. Despite extensive internal controls, there is considerable
noise in the experimental technique. In many cases, variability is inherent within the
samples themselves, this topics are discussed more in detail in future section. Micro-
organisms can be cloned; animals can be inbred to a comparable degree of homogeneity.
However, experiments using RNA from human sources-for example, a set of patients
suffering from a disease and a corresponding set of healthy controls-are at the mercy
of the large individual variations that humans present. Indeed, inbred animals, and even
apparently identical eukaryotic tissue-culture samples, show extensive variability. An-
other intrinsic disadvantage-and a severe one-in interpreting gene expression data, is the
fact that the number of genes is much larger than the number of samples. Two general
approaches to the analysis of a gene expression matrix involve
• Comparisons focussed on the genes; that is, comparing distributions of expression
patterns of different genes by comparing rows in the expression matrix: How do
gene expression patterns vary among the different samples? Suppose a gene is
known to be involved in a disease, or to a change in physiological state in response
to changed conditions. Other genes co-expressed with the known gene may par-
ticipate in related processes contributing to the disease or change in state. More
generally, if two rows (two genes) of the gene expression matrix show similar
expression patterns across the samples, this suggests a common pattern of regu-
lation, and possibly some relationship between their functions, including but not
limited to a possible physical interaction.
• comparisons focussed on samples; that is, comparing expression profiles of dif-
ferent samples by comparing columns of the expression matrix: Comparisons fo-
cussed on samples: How do samples differ in their gene expression patterns? A
consistent set of differences among the samples may characterize the classes from
which the samples originate. If the samples are from different controlled groups
(for instance, diseased and healthy animals), do samples from different groups
show consistently different expression patterns? If so, given a novel sample, we
can assign it to its proper class on the basis of its observed gene expression pattern.
To know more details of the matrix SVD (Singular Value Descomposition) see chap-
ter 2 from the book [15].
How then do we measure the similarity of different rows or columns? Each row or
column of the expression matrix can be considered as a vector, in a space of many dimen-
sions. The row-vectors (a row corresponds to a gene), each entry of which refers to the
same gene in different samples, has as many elements as there are samples. The column-
vectors (a column corresponds to a sample), each entry of which refers to a different gene
in a single sample, has as many elements as there are genes reported. It is possible to cal-
culate the ’angle’ between different row-vectors, or between different column-vectors,
to provide a measure of their similarities. It is then natural to ask whether subsets of the
points form natural clusters-points with high mutual similarity-characterizing either sets
of genes or sets of samples.
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Minimal Information About a Microarray Experiment
Microarray analysis results in the gathering of massive amounts of information concern-
ing gene expression profiles of different cells and experimental conditions. Analyzing
these data can often be a quagmire, with endless discussion as to what the appropriate
statistical analyses for any given experiment might be. As a result many different meth-
ods of data analysis have evolved, the basics of which are outlined in this chapter.
In an effort to standardize the thousands of array experiments, the Microarray
Gene Expression Database (MIAME) society established guidelines that require re-
searchers to conform to MIAME guidelines. MIAME describes the minimal informa-
tion about a microarray experiment that is required to interpret the results of the ex-
periment, and compare it with other experiments from other groups. The checklist
for complying with the MIAME guidelines is quite extensive and can be found at
http : //www.mged.org/Workgroups/MIAME/miamechecklist.html In brief,
these guidelines include:
• Array design: information regarding the platform of the array, description of
the clones and oligomers, and catalog numbers for commercial arrays. This also
should include the location of each feature as well as the explanations of feature
annotation.
• Experimental design: a description and the goals of the experiment, rationale for
cells/tissues and treatment used, quality control steps, and links to any public
databases necessary.
• Sample selection: criteria for the selection of samples, description of the proce-
dures used for RNA extraction, and sample labeling.
• Hybridization: conditions of hybridization, including blocking and washing of
slides.
• Data analysis: description of the raw data, as well as of the original images, hard-
ware, and software used, and also the criteria used for processing and normaliza-
tion of data.
Image Acquisition and Analysis
Once the RNA has been isolated and hybridized to the chip, the first stage of data analysis
begins. This requires successful acquisition of the fluorescent or radioactive signal bound
to the chip or membrane. With radioactive membranes, it is standard procedure to expose
the membrane several times and then take an educated average of the best exposures.
With fluorescent dyes, it is essential to utilize a high-resolution scanner and that the first
scan be performed as quickly and accurately as possible, as the dyes are quickly bleached
and multiple scans are not possible. Some salient points of image acquisition are outlined
next.
Quality of Scanner
It is important to use a scanner that can detect at a resolution of 10 microns or greater.
In addition, the scanner must be able to excite and detect Cy3 (532 nm) and Cy5 fluo-
rescence (633 nm). An adjustable photomultiplier tube to ensure equal scanning, while
reducing as much bleaching as possible, is also ideal. Typically, the settings for the pho-
tomultiplier tube are around 30
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Orientation of Image
The orientation of the image becomes particularly important when combining arrays
from one company with a scanner from a different company as images may be inverted
depending on the scanner being used. Thus, it is crucial that the array include "land-
ing lights"-control cDNAs or oligonucleotides spotted on the arrays that yield a distinct
pattern when the array is in the correct orientation.
Spot Recognition
Often referred to as "gridding," this is the process used to identify each spot on the
array prior to extracting information from it. When purchasing arrays and scanners from
commercial sources, programs for spot recognition and information extraction are often
included. Agilent and Affymetrix both have their ownfeature extractor software, which
uses control spots on the array for automated spot recognition and feature extraction.
Many other programs require that the user intervene and flag "bad" spots, and realign
grids to fit the spots.
Segmentation
Once grids have been placed, information as to the pixel intensity within the spots must
be extracted. This process is known as segmentation. Various methods exist to perform
this including fixed circle segmentation, adaptive circle segmentation, fixed shape seg-
mentation, adaptive shape segmentation, and seeded region growing method (also known
as the histogram-based method).
Analysis of the Quality of the Hybridization
All of these imaging parameters can then be used to analyze the quality of the microarray
experiment. Intensities in each channel should ultimately cluster around a central norm
in a Gaussian distribution. Background intensity abnormalities can be calculated statis-
tically by computing the average background intensity and using the standard deviation
among this intensity to calculate a confidence interval, the upper limit of which is used
to assume background correction.
Data Normalization
In order to normalize the information received from a microarray experiment, several
methods have been designed and are outlined next.
Data Transformation
After background correction has been performed, the data must be transformed for sta-
tistical analysis. The analyses applied to the data (e.g., parametric vs nonparametric)
determine the type of transformation that must be performed. Parametric tests are the
most commonly utilized, as these tests are much more sensitive and require the data to
be normally distributed. This is often achieved by using log transformation of the spot
intensities to achieve a Gaussian distribution of the data.
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Differential Gene Expression
Differential gene expression is often measured by the ratio of intensity (as a measure
of expression level) between two samples. Many early microarray experiments assigned
a fold-change cutoff, and considered genes above this fold-change significant. In addi-
tion, several statistical analyses can be utilized including maximum-likelihood analysis,
F-statistic, ANOVA (analysis of variance), and t-tests. The results of these tests can of-
ten be improved by log transformation of data as mentioned previously, and by random
permutations of the data.
Pattern Discovery
Often called exploratory or unsupervised data analysis, this approach can encompass a
number of different techniques listed next that allow for a global view of the data. These
methods often rely on clustering techniques that allow for quick viewing of distinct gene
expression patterns within a dataset. Cluster analysis is available free of charge as part
of the gene expression omnibus, a site that attempts to catalog gene expression data (16),
providing a valuable data mining resource (http://www.ncbi.nlm.nih.gov/geo/). Dimen-
sion reduction techniques such as principal component analysis (PCA) and multidimen-
sional scaling analysis can often be used in conjunction with other supervised techniques
such as artificial neural networks to provide even more robust data analysis.
PCA
PCA can analyze multivariate data by expressing the maximum variance as a minimum
number of principal components. Redundant components are eliminated, thus reducing
the dimensions of the input vectors. For information on the mathematical origins of this
equation, see http://www.cis.hut.fi/ jhollmen/ dippa/node30.html.
Multidimensional Scaling
This analysis is often based on a pair-wise correlation coefficient and assesses the simi-
larities and dissimilarities between samples and assigns the difference as a "distance" be-
tween samples, such that the more similar two samples are, the closer they are together,
and vice versa. The multi- as opposed to twodimensional analysis comes into play when
not only the degree of difference (distance) but also the spatial relationship of three or
more samples to each other (direction) is taken into account. For further mathematical
description of this process, see http://www.statsoft.com/textbook/stmulsca.html.
Singular Value Decomposition
Singular value decomposition (SVD) treats microarray data as a rectangular matrix, A,
which is composed of n rows (genes) by p columns (experiments). SVD is represented
by the mathematical equation.
Hierarchical Clustering
Perhaps the most familiar to biologists, hierarchical clustering presents the data as a
gene list organized into a dendrogram, and is a bottom-up analysis. This is obtained
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by assigning a similarity score to all gene pairs, calculating the Pearson’s correlation
coefficient, and then building a tree of genes by replacing the two most similar genes
with a node that contains the average, then repeating the process for the next closest pair
of data points, and then the next. This process is repeated several times (iterative process)
to generate the dendrogram or Treeview, as well as heat maps that represent a two-color
checkerboard view of the data.
K-Means Clustering
K-means clustering is a top down technique that groups a collection of nodes into a fixed
number of clusters (k) that are subjected to an iterative process. Each class must have a
center point that is the average position of all the distances in that class (representative
element), and each sample must fall into the class to which its center is closest. Fuzzy
k-means is performed by "soft" assignment of genes to these clusters.
Self-Organizing Maps
These maps are basically two dimensional grids containing nodes of genes in "K" di-
mensional space. These can be represented by sample and weight vectors, which are
composed of the data and their natural location. Weight vectors are initialized, and then
sample vectors are randomly selected to determine which weight best represents that
sample, and these are used to map the nodes into K-dimensional space into which the
gene expression data falls. Like the previously mentioned methods, this is also iterative
and is often repeated more than 1000 times, and these methods can often be used in
combination to generate the best overview of the data.
Class Prediction
Class prediction is based on supervised data analysis methods that impose known groups
on datasets. First, a training set is identified-this is a group of genes with a known pattern
of expression that is used to "train" a dataset, by comparing the data to the training set
and thus classifying it. This particular method is very useful in the subclassification of
similar samples, cancer diagnosis, or to predict cell or patient response to drug therapy. In
some cases, this type of analysis has also been used to predict patient outcome, allowing
for a very clinically relevant use of microarray data. Importantly, gene selection by these
methods relies on the assignment of discriminatory weights to these genes, i.e., how often
a single gene correlates to a given class or phenotype, often calculated using random
permutation tests. Random permutation tests are also used to calculate p (probability the
weight can be obtained by chance) and (probability of high weight resulting from random
classification) values for these weights. Many different statistical methods can be used to
find discriminant genes.
Fisher Linear Discriminant Analysis
This theory assumes that a random vector x has a multivariate normal distribution be-
tween each defined class or group, and the covariance within each group is identical for
all the groups. This makes the optimal decision function for the comparison of data a lin-
ear transformation of x. Variations on this theme include quadratic discriminant analysis,
flexible discriminant analysis, penalized discriminant analysis, and mixture discriminant
analysis.
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Nearest-Neighbor Classification
These methods are based on a measure of distance (e.g., Euclidean distance) between
two gene expression profiles. Observations are given a value (x) and the number of ob-
servations (k) closest to x is used to choose the class. The value of k can be determined
by using cross-validation techniques.
Support Vector Machines
This type of analysis is based on constructing planes in a multidimensional space that
separate the different classes of genes, and set decision boundaries using an iterative
training algorithm. Data is mapped into the higher dimensional space from its origi-
nal input space, and a nonlinear decision boundary is assigned. This plane is known
as the maximal margin hyperplane, and can be located by the use of a kernel func-
tion (a nonparametric weighting function). For further mathematical description, see
http://www.statsoft. com/textbook/stsvm.html.
Artificial Neural Networks
Neural networks, or perceptrons, another machine-learning technique, are so named be-
cause they model the human brain-they learn by experience. Multilayer perceptrons can
be used to classify samples based on their gene expression. Gene expression data for a
sample are input into the model, and a response is generated in the next layer, ultimately
triggering a response in the output layer. This output perceptron should represent the
class to which the sample belongs.
Decision Trees
These are built by using criteria to divide samples into nodes. Samples are divided re-
cursively until they either fall into partitions, or until a termination condition is met. Ul-
timately the intermediate nodes represent splitting points or partitioning criteria, and the
leaf nodes represent those decisions.
Data Validation
As complex and robust as the available analyses for microarray data currently are, there
is always room for error, and many inherent problems in the experimental technique.
Thus, it is critical that researchers validate their data before drawing any firm biologi-
cal conclusions from the data. One of the most common techniques for validating array
data is the use of real-time PCR. Real-time PCR effectively quantitates differences in
transcript levels between different samples, but it must be remembered that the ratios ac-
quired from a microarray experiment are quite likely to be much lower than fold changes
seen in real-time PCR, as this method is much more sensitive. Ultimately, protein expres-
sion is of course the final confirmation, as most gene expression-profiling experiments,
whether of a classifier or exploratory nature seek protein markers, and this is most often
confirmed using immunohistochemistry.
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3. The Use of CBR in Bioinformatics
Intelligent support is essential for managing and interpreting this overwhelming amount
of data, and one of the most important tasks faced currently is the analysis of sequences of
nucleotides in order to locate the areas of DNA that actually encode functional biological
information [2].
Bioinformatics incorporates the fields of biology, computer science and information
technology with the goal of discovering new biological insights and the enhancement of
diagnostic and pharmaceutical medicine. Sequence analysis, which involves the study
of an organism’s DNA in an effort to understand its molecular structure and underlying
functionality, is of major importance to the area of gene therapy, which has led to the
discovery of mutations in DNA and chromosomal abnormalities indicative of diseases
such as cancer. Thus the analysis of nucleotide sequences, in particular the identification
of DNA segments that encode functional biological information, can provide the medical
profession with invaluable insight into the pathology of disease state and treatment.
Sequence analysis first involves determining the basic molecular structure of an or-
ganism’s DNA, which is simply a molecule made up of two strands, with each strand
comprised of nucleotides from a finite set. There are four different nucleotides-adenine,
guanine, thiamine and cytosine, and the first letter of each provides an alphabet {A,G,
T,C} for representing DNA. A nucleotide to nucleotide bond holds the two strands to-
gether with each nucleotide being bonded to its complementary match, a only bonding
to T and C only bonding to G. Therefore, given one strand (i.e., half a DNA molecule),
the complementary strand can be reconstructed relatively easily. Determining the basic
molecular DNA structure sequence is a well understood task that is providing a del-
uge of information for interpretation. The task of "gene finding," identification of cod-
ing regions in an organism’s DNA, is the next essential step in analysing an organism’s
genome. These coding regions are called exons and when these are put together they
form an entire gene. It is the genes that tell the body how to create proteins, and it is these
that give rise to biological function. Exons are continuous sequences in a strand that the
body uses to replicate proteins; the parts in between these exons do not contribute to
protein replication and are called introns, or non coding regions.
• In the research work [2] are interested in applying CBR to the gene-finding prob-
lem by employing a case library of nucleotide segments that have previously been
categorised as coding (exon) or non-coding (intron), in order to locate the coding
regions of a new DNA strand. The work describes the initial research in develop-
ing a CBR approach to the problem of finding regions in mammalian DNA that
code proteins essential for life.
An initial system was tested and evaluated the results and conclude it is evident
that a simple case-based reasoning approach to the recognition of coding regions
is certainly possible.
They presented their initial work in applying a case-based approach to the prob-
lem of gene-finding in mammalian DNA. The results obtained from the approach
indicate that it is certainly feasible to do DNA-to-DNA comparisons in order to
isolate relevant coding regions. Using DNA sequences, avoids the need for the
translation of the sequence to the different protein sequence possible.
• In the research work [3] presents an approach to performing the case-based
paradigm in the presence of noisy DNA sequences (case boundaries). The ap-
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proach has been fully implemented and applied in the domain of molecular biol-
ogy; specifically, a successful case-based approach to gene finding is described.
They have developed a case-based algorithm for gene finding that is robust in
the presence of frame shift errors. The FIND-IT algorithm builds on the BLAST
similarity-search program. BLAST efficiently produces approximate matches, but
these matches do not extend across frame shift errors. The FIND-IT method de-
scribed below coherently combines partial matches (to a given protein) in different
reading frames, thereby overcoming missing and extra nucleotides in sequenced
DNA.
Is presented a case-based approach to gene finding that is robust in the presence
of errors both in the input data and in the case libraries. The research addresses
the important general question of what makes a case; more specifically, how do
parse the "noisy" world into discrete cases for matching against a case library? If
the current case is improperly delimited, partial matching with previous cases will
fail. The algorithm addresses the problem by producing multiple, partial matches
to many cases and then combining some subset of them into a consistent whole.
This leads to error detection and correction. The general idea for robust case
matching promises to be applicable in other domains involving "continuous" data,
such as speech recognition and vision.
• The research work [4] presents a reduction algorithm based on the notion of fuzzy
gene expression, where similar (co-expressed) genes belonging to different pa-
tients are selected in order to construct a supervised prototype-based retrieval
model. This technique is employed to implement the retrieval step in the new
gene-CBR system. They propose a fuzzy codification for the gene expression lev-
els of each sample based on the discretization of real gene expression data into a
small number of fuzzy membership functions.
In this work, is presented a fuzzy codification for the gene expression levels of
microarray data, based on the discretization of real gene expression data into a
small number of fuzzy membership functions. The proposed method aims to find
all genes that are significantly expressed between the existing classes in order to
obtain a fuzzy representation of the expression levels belonging to those genes
that best explain each class in the form of a fuzzy-prototype.
• In [5] presents GENE-CBR, a hybrid model that can perform cancer classification
based on microarray data. The system employs a case-based reasoning model that
incorporates a set of fuzzy prototypes, a growing cell structure network and a set
of rules to provide an accurate diagnosis.
The hybrid system proposed presents a new synthesis that brings several artificial
intelligence subfields together (fuzzy sets, artificial neural networks, and if-then
rule-sets).
GENE-CBR is a model that can perform cancer classification based on microar-
ray data. GENE-CBR employs a CBR model that incorporates a set of fuzzy pro-
totypes for the retrieval of relevant genes, a growing cell structure (GCS) network
and a proportional weighted voting algorithm for the clustering of similar patients
and the assignation of an initial class, and a set of rules used to formalize the
knowledge extraction to justify the results. For the experiments reported they work
with a database of bone marrow (BM) cases from forty-three adult patients with
acute myeloid leukemia (AML) plus a group of six samples belonging to healthy
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persons for test purposes. Each case (microarray experiment) stores 22,283 ESTs
corresponding to the expression level of thousands of genes. The data consisted
of 1,025,018 scanned intensities.
To initially construct the model case base starting from the available patients data,
GENE-CBR stores the gene expression levels of each sample in its case base. The
system always deals with a fuzzy codification of the values stored. During the
retrieval stage, the original case vectors are transformed into a fuzzy microarray
descriptors (FMD). Each FMD is a comprehensible descriptor of the sample in
terms of a linguistic label for each gene expression level. This transformation is
carried out by mean of a fuzzy discretization process.
The retrieval stage in the GENE-CBR system uses the FPs to select the most
representative genes given a new patient. The GENE-CBR system selects those
FP from its case base which are the nearest to any new case obtained. Then, for
each one of the selected FPs, the GENE-CBR system computes its associated
discriminant fuzzy pattern (DFP) (a pattern which only includes the genes that are
necessary to discriminate the novel instance from other different classes). Finally,
the selected genes for the new case are obtained by joining together the genes
belonging to the DFPs considered. A GCSs network is trained with the whole
case base, only taking the existing cases represented by the genes selected in the
previous stage as input. A proportional weighted voting mechanism is applied that
ponders the level of similarity with the new FMD.
They are interested in the development of a robust case-based reasoning system
that may be employed in the study of cancer treatment. The goal of the decision
support tool is to facilitate the construction of therapies, including the level of
aggressiveness of treatment, to more closely match the underlying disease, hope-
fully reducing side effects in low risk cases and increasing cure rates in high-risk
cases. Input space reduction is often the key phase in the building of an accurate
classifier. Based on the fuzzy discretization method presented, and propose the
use of a fuzzy prototype-based retrieval system able to differentiate several kinds
of cancer for microarray data.
The proposed method aims to find all genes that are significantly expressed be-
tween the existing classes in order to obtain a fuzzy representation of the expres-
sion levels belonging to those genes that best explain each class in the form of
a fuzzy-prototype. The final goal is the application of the proposed method as a
retrieval step for the gene-CBR system.
CBR and Cancer
Recently, knowledge discovery techniques, such as decision trees, neural networks, sup-
port vector machines and case-based reasoning, have been applied increasingly to im-
prove medical decision-making and to the diagnosis, prognosis and prescription of car-
diovascular diseases, cancer, diabetes, chronic lower respiratory diseases and many other
medical problems.
CBR has been used to solve various problems, such as in financial forecasting, credit
analysis and medical diagnosis. The advantages of CBR are its ease of learning and ex-
planatory capability. For example, although one of the prevalent knowledge extraction
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methods, neural networks, has received a great deal of attention because of its high pre-
dictability, its lack of an explanatory capability constrains its use in many areas. In con-
trast, with CBR it is relatively easy to understand how the results are produced and which
cases are used for them, so it can be an appropriate method for many real-world areas
that need explanation. Another advantage of CBR is that it can still be effective if the
knowledge base or domain theory is incomplete. Certain techniques of automated learn-
ing, such as explanation based learning, work well only if a strong domain theory exists,
whereas CBR can use many examples to overcome the gaps in a weak domain theory,
while still taking advantage of the domain theory.
Case-based reasoning (CBR) has been applied relatively less frequently in medicine
than other methods. Recently, however, CBR has been used for various medical prob-
lems, such as an antibiotics therapy advice system, diet recommendation, care of
Alzheimer’s disease patients, diagnosing Alzheimer’s disease, heart failure and pul-
monary disease, and for managing diabetes mellitus.
• In the research work [1] presents two applications for the breast cancer treatment
decision helping. The first one is called Casimir/RBR and can be likened to a
rule-based reasoning system. In some situations, the application of the rules of
this system does not provide a satisfying treatment. Casimir/CBR uses principles
of case-based reasoning in order to suggest solutions by adapting the rules of
Casimir/RBR. the rules are considered as cases: they are adapted rather than used
literally.
Most important in the framework is about the way the knowledge units -rules or
cases- are used:
∗ The rules are (typically) used literally; the conclusion of the rule is simply
instantiated.
∗ The cases are adapted and not simply copied or instantiated.
The difference between a case and a rule is not based on their contents but on the
different ways they are used.
Thus, the same knowledge units can be used to do reasoning from rules or from
cases. In particular, a rule R = (Prem → Cclo) can be seen as a case whose
problem is the premise Prem of R and whose solution is the conclusion Cclo of R.
This is the principle that has been adopted for the two applications Casimir/RBR
(which can be seen as a RBR application) (and Casimir/CBR) which can be seen
as a CBR application.
The use of RBR (in fact, of hierarchical classification) in order to model the rea-
soning of Casimir/RBR is deeply inspired from the system Resyn whose domain
is the synthesis planning in organic chemistry.
The system Resyn/CBR can be seen as an extension of Resyn, the difference being
essentially due to the fact that RBR is followed by CBR in Resyn/CBR.
The part of the application Casimir/CBR which should be the most similar to
Resyn/CBR. The technique used for retrieval in Resyn/CBR is smooth classifica-
tion. For the part of Casimir/CBR dealing with situations, the same technique is
scheduled.
Casimir/RBR and Casimir/CBR, that are dedicated to decision helping in the
framework of breast cancer treatment. The second one uses case-based reasoning
in an unusual way: the rules of Casimir/RBR are used as cases for Casimir/CBR.
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• In research work [6] explores how data mining and knowledge discovery can be
applied to medical informatics using human gene information. They applied case-
based reasoning to a cancer detection problem using human gene information
and SNP analysis because case-based reasoning has been applied in medicine
relatively less often than other data mining techniques. Proposed a modified case-
based reasoning method that is appropriate for associated categorical variables to
use in detecting gastric cancer.
The work shows how CBR can resolve a cancer detection problem using human
gene information and SNP analysis. Propose a modified CBR method, which is
appropriate for use with associated categorical variables, to detect cancer using
SNP data based on a haplotype analysis. The associated information between
genes needs to be considered in a diagnostic model. This modified CBR method
can convert the original data into haplotype data because combinations of SNP
data can enhance the accuracy.
They proposed a modified CBR method to fit a specific medical domain, and
developed a CBR method that uses associated informative data for gastric cancer
detection. previous data mining techniques have used simple gene information.
Therefore, the modified CBR method needs to consider the associated information
between genes for the medical diagnostic model.
4. The Microarrays and CBR
Molecular biology domain is a natural application for CBR systems, since CBR systems
can perform remarkably well on complex and poorly formalized domains. However, due
to the large number of attributes in each case, CBR classifiers, similarly as other learning
systems, suffer from the "curse of dimensionality". Maintaining CBR systems can im-
prove the prediction accuracy of CBR classifiers by clustering similar cases, and remov-
ing "non-informative" features in each group. Focus on integrating clustering and feature
selection techniques with CBR systems to enhance the accuracy of CBR classifiers.
In the research work [7], is proposed a maintenance technique that integrates an
ensemble of CBR classifiers with spectral clustering and logistic regression to improve
the classification accuracy of CBR classifiers on (ultra) high-dimensional biological data
sets. They demonstrate the improvement achieved by applying the method to a compu-
tational framework of a CBR system called TA3. The maintenance method improves the
classification accuracy of TA3 by approximately 20% from 65% to 79% for the leukemia
and from 60% to 70% for the lung cancer data set. Two examples used in this paper in-
volve the profiling of gene and protein expression using microarrays and mass spectrom-
etry.
The main challenge is to interpret the molecular biology data to find similar sam-
ples to eventually use them in case-based medicine, and to identify those genes whose
expression patterns have meaningful relationships to their classification labels whose ex-
pression patterns help better understand cancer initiation and progression. Clustering and
feature selection techniques have been successfully applied to CBR maintenance; how-
ever, they show how those techniques can further improve the prediction accuracy of a
CBR classifier when combined with mixture of experts to analyze microarray data sets.
The CBR maintenance approach has three main components: ensemble of CBR systems,
CBR and Microarrays 19
clustering, and feature selection. Use an ensemble of CBR systems, called mixture of
experts (MOE) to predict the classification label of a given (input) case. A gating net-
work calculates the weighted average of votes provided by each expert. The performance
of each CBR expert is further improved by using clustering and feature selection tech-
niques. Apply spectral clustering to cluster the data set into k groups, and the logistic
regression model is used to select a subset of features in each cluster. Each cluster is
considered as a case-base for the k CBR experts, and the gating network learns how to
combine the responses provided by each expert.
Smyth on his research say that differents CBR maintenance methods can be catego-
rized into two Groups Competence-directed and Efficiency-directed.
Mixture of experts approach is based on the idea that each expert classifies samples
separately, and individual responses are combined by the gating network to provide a
final classification label.
The goal of the maintenance method (MOE4CBR) is to improve the prediction accu-
racy of CBR classifiers, when combined with the mixture of experts approach to analyze
microarray and mass spectrometry data sets, and at the same time reduce the size of the
case-base knowledge container. According to Smyth’s categorization, the maintenance
method Mixture of Experts for CBR systems (MOE4CBR) is both competence directed,
since the range of the problems the system can solve increases and efficiency directed,
since the size of case base decreases. The integration approach mixture of experts for
case-based reasoning (MOE4CBR) is comprised of three main components:
• An ensemble of CBR systems to predict the classification label for a given input
case;
• Clustering to organize data set (case-base) into k homogeneous groups; and
• Feature selection to characterize each cluster by a subset of informative features.
The performance of each expert in MOE4CBR is improved by using clustering and
feature selection techniques. Based on the initial analysis, they selected spectral cluster-
ing for clustering the case-base, and the logistic regression model as a filter feature se-
lection for the TA3 classifier. Given a labeled training data set, the system predicts labels
for the unseen data (test set).
The earlier evaluation suggests that spectral clustering outperforms k-means cluster-
ing and SOMs. The comparison was based on two criteria:
• Dunn’s index, which does not require class labels and identifies how "compact
and well separated" clusters are.
• Precision and recall that compare the resulting clusters with pre-specified class
labels. Precision shows how many data points are classified (clustered) correctly,
and recall shows how many data points the model accounts.
The MOE4CBR maintenance method has two main steps: first, the case-base of
each expert is formed by clustering the data set into k groups, then each case-base is
maintained "locally" using feature selection techniques. Each of the k obtained sets will
be considered as a case-base for k CBR experts. Each expert applies the TA3 model to
decide on the class label, and the gating network uses TA3 to assign weights to each
classifier.
Fisher criterion and standard t-test are two statistical methods that have been suc-
cessfully applied to feature selection problem in (ultra) high-dimensional data sets. In
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order to select a suitable feature selection approach for CBM, they have evaluated perfor-
mance of Fisher criterion, t-test, and the logistic regression model when used in a CBR
classifier. Namely, they have applied the three feature selection techniques to the TA3
classifier, and measured the improvement in accuracy and classification error. Accuracy
measures the number of correctly classified data points, and classification error counts
the number of misclassified data points. Based on the evaluation, logistic regression ap-
plied to feature selection outperforms Fisher and standard t-test techniques.
They contribution can be summarized as follows: First, they have demonstrated that
integrating the CBR paradigm with data mining and feature selection improves its predic-
tion accuracy in high-dimensional biomedical domains. Second, they shown that spec-
tral clustering outperforms SOMs and k-means clustering, the two clustering methods
widely used in analyzing microarrays and mass spectrometry data sets. Third, reported a
novel use of logistic regression as a filter feature selection method for a CBR classifier.
5. Conclusions and Future Work
The Bioinformatics field has been briefly reviewed, and the Microarrays were analyzed
more deeply. The microarrays it’s a new area in computer science. In fact the literature
about the topic shown that there are many research works moving to it. New designs
exploiting the characteristics of microarrays, especially innovation and developing new
algorithms are seen in this field. For us, the immersion in this information leave us the
idea of apply experiments using the matrix of arrays and the structure of cases as back-
bone to consolidate the research of applying polices based on microarrays, and define
a novel policy in the case-based maintenance, based in the mixture of the structure of
microarrays and CBR.
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